Analysis of FMR1 gene premutation and X chromosome cytogenetic abnormalities in 100 Tunisian patients presenting premature ovarian failure

Annales d'Endocrinologie

Volumn 76, Issue 6, 2015, Pages 671-678

  Bouali, Nouha ^a   Hmida, Dorra ^a   Mougou, Soumaya ^a   Bouligand, Jérôme ^b,c   Lakhal, Besma ^a   Dimessi, Sarra ^a   Francou, Bruno ^b,c   Saad, Ghada ^a   Trabelsi, Saoussen ^a   Zaouali, Monia ^a   Gribaa, Moez ^a   Chaieb, Molka ^a   Bibi, Mouhamed ^a   Guiochon Mantel, Anne ^b,c   Saad, Ali ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

FMR1 gene; Premature ovarian failure (POF); Premutation allele; X chromosome abnormalities

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE; AFF2 PROTEIN, HUMAN; FMR1 PROTEIN, HUMAN; FRAGILE X MENTAL RETARDATION PROTEIN; NUCLEAR PROTEIN;

ADULT; ALLELE; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME MOSAICISM; COHORT ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; ENDOCRINOLOGIST; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE FERTILITY; FLUORESCENCE IN SITU HYBRIDIZATION; FMR1 GENE; FMR2 GENE; FOLLITROPIN BLOOD LEVEL; FRAGILE X SYNDROME; GENE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC COUNSELING; GYNECOLOGIST; HUMAN; KARYOTYPE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; OVARY FUNCTION; PREMATURE OVARIAN FAILURE; PREVALENCE; TESTOSTERONE BLOOD LEVEL; TUNISIAN; X CHROMOSOME; BLOOD; GENETICS; KARYOTYPING; MOSAICISM; MUTATION; SEX CHROMOSOME ABERRATION; TUNISIA;

ADULT; ALLELES; CHROMOSOMES, HUMAN, X; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LUTEINIZING HORMONE; MOSAICISM; MUTATION; NUCLEAR PROTEINS; PRIMARY OVARIAN INSUFFICIENCY; SEX CHROMOSOME ABERRATIONS; TUNISIA;

EID: 84949661307     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2015.10.001     Document Type: Article

References (35)

1. Coulam C.B., Adamson S.C., Annegers J.F. Incidence of ovarian failure. Obstet Gynecol 1986, 67:604-606.
2. Goswami D., Conway G.S. Premature ovarian failure. Horm Res Pediatr 2007, 68:196-202.
3. Simpson J.L., Rajkovic A. Ovarian differentiation and gonadal failure. Am J Med Genet 1999, 89:186-200.
4. Persani L., Rossetti R., Cacciatore C. Genes involved in human premature ovarian failure. J Mol Endocrinol 2010, 45:257-279.
5. Zinn A.R., Page D.C., Fisher E.M. Turner syndrome: the case of the missing sex chromosome. Trends Genet 1993, 9:90-93.
6. Zinn A.R., Ross J.L. Turner syndrome and haploinsufficiency. Curr Opin Genet Dev 1998, 8:322-327.
7. Wittenberger M.D., Hagerman R.J., Sherman S.L., McConkie-Rosell A., Welt C.K., Rebar R.W., et al. The FMR1 premutation and reproduction. Fertil Steril 2007, 87:456-465.
8. Bardoni B., Mandel J.L. Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes. Curr Opin Genet Dev 2002, 12:284-293.
9. Murray A. Premature ovarian failure and the FMR1 gene. Semin Reprod Med 2000, 18:59-66.
10. Allen E.G., Sullivan A.K., Marcus M., Small C., Dominguez C., Epstein M.P., et al. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod 2007, 22:2142-2152.
11. Hunter J.E., Epstein M.P., Tinker S.W., Charen K.H., Sherman S.L. Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity. Genet Epidemiol 2008, 32:553-559.
12. Biancalana V., Glaeser D., McQuaid S., Steinbach P. EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders. Euro J Hum Genet 2015, 23:417-425.
13. Sullivan A.K., Marcus M., Epstein M.P., Allen E.G., Anido A.E., Paquin J.J., et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 2005, 20:402-412.
14. Jin M., Yu Y., Huang H. An update on primary ovarian insufficiency. Sci China Life Sci 2012, 55:677-686.
15. Murray A., Webb J., Dennis N., Conway G., Morton N. Microdeletion in FMR2 may be a significant cause of premature ovarian failure. J Med Genet 1999, 36:767-770.
16. Gatta V., Gennaro E., Franchi S., Cecconi M., Antonucci I., Tommasi M., et al. MS-MLPA analysis for FMR1 gene: evaluation in a routine diagnostic setting. BMC Med Genet 2013, 14:79.
17. Lakhal B., Braham R., Berguigua R., Bouali N., Zaouali M., Chaieb M., et al. Cytogenetic analyses of premature ovarian failure using karyotyping and interphase fluorescence in situ hybridization (FISH) in a group of 1000 patients. Clin Genet 2010, 2:181-185.
18. Cramer D.W., Xu H., Harlow B.L. Family history as a predictor of early menopause. Fertil Steril 1995, 64:740-745.
19. Vegetti W., Tibiletti M.G., Testa G., Yankowski D.L., Alagna F., Castoldi E., et al. Inheritance in idiopathic premature ovarian failure: analysis of 71 cases. Hum Reprod 1998, 13:1796-1800.
20. Schlessinger D., Herrera L., Crisponi L., Mumm S., Percesepe A., Pellegrini M., et al. Genes and translocations involved in POF. Am J Med Genet 2002, 111:328-333.
21. Portnoi M.F., Aboura A., Tachdjian G., Bouchard P., Dewailly D., Bourcigaux N., et al. Molecular cytogenetic studies of Xq critical regions in premature ovarian failure patients. Hum Reprod 2006, 9:2329-2334.
22. Baronchelli S., Conconi D., Panzeri E., Bentivegna A., Redaelli S., Lissoni S., et al. Cytogenetics of premature ovarian failure: an investigation on 269 affected women. J Biomed Biotechnol 2011, [Article ID 370195, 9]. 10.1155/2011/370195.
23. Speed R.M. The possible role of meiotic pairing anomalies in the atresia of human fetal oocytes. Hum Genet 1988, 78:260-266.
24. Ogata T., Matsuo N. Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet 1995, 95:607-629.
25. Zinn A.R. The X chromosome and the ovary. J Soc Gyn Invest 2001, 8:S34-S36.
26. Lam lT, Preyer O., Umek W., Hengstschlager M., Hanzal E. Genetic disorders in premature ovarian failure. Hum Reprod Update 2002, 8:483-491.
27. Conway G.S., Kaltsas G., Patel A., Davies M.C., Jacobs H.S. Characterization of idiopathic premature ovarian failure. Fertil Steril 1996, 65:337-341.
28. Gleicher N., Weghofer A., Barad D.H. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil Steril 2009, 91:1700-1706.
29. Rousseau F., Rouillard P., Morel M.L., Khandjian E.W., Morgan K. Prevalence of carriers of premutation-size alleles of the FMRI gene and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 1995, 57:1006-1018.
30. Conway G.S., Payne N.N., Webb J., Murray A., Jacobs P.A. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod 1998, 13:1184-1187.
31. Bussani C., Papi L., Sestini R., Baldinotti F., Bucciantini S., Bruni V., et al. Premature ovarian failure and fragile X premutation: a study on 45 women. Eur J Obstet Gynecol Reprod Biol 2004, 112:189-191.
32. Bretherick K.L., Fluker M.R., Robinson W.P. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 2005, 117:376-382.
33. Murray A., Webb James, Dennis N., Conway G., Morton N. Microdeletions in FMR2 may be a significant cause of premature ovarian failure. J Med Genet 1999, 36:767-770.
34. Sherman S., Pletcher B.A., Driscoll D.A. Fragile X syndrome: diagnostic and carrier testing. Genet Med 2005, 7:584-587.
35. van Kasteren Y.M., Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999, 5:483-492.